maps glp 1 program GLP-1 COACHING Designing GLP-1 delivery: structural perspectives

I like the work, I like watching the numbers crawl up, and I love being fitter than I ever was at 30 or 40

Liraglutide (Victoza, Saxenda) : Approved for type 2 diabetes (1.8 mg daily) and chronic weight management (3.0 mg daily)

This case underscores the critical need for clinical oversight, especially in high-stakes professions where cognitive performance is nonnegotiable

That clinical evidence applies to FDA-approved versions of these active ingredients

Unlike other forms of hair loss that happen slowly, "GLP-Shedding" accelerates

Here is what has occurred and what patients may expect in the coming months based on manufacturer announcements and regulatory filings: December 22, 2025: FDA approved oral Wegovy (semaglutide 25 mg), the first oral GLP-1 for weight loss